ASH 2014 | ASH 2014: Managing diffuse large B-cell lymphoma

Name: ASH 2014: Managing diffuse large B-cell lymphoma
Uploaded: 2014-12-05T00:00:00Z
Duration: 1 min 14 s
Description: At the 2014 American Society of Hematology (ASH) Annual Meeting, Prof Christian Gisselbrecht (St. Louis Hospital, Paris, France) discusses the molecular approach in managing diffuse large B-cell lymphoma (DLBCL). The molecularly defined DLBCL subtypes, germinal centre B-cell-like (GCB)-DLBCL and activated B-cell-like (ABC)-DLBCL, have important clinical implications.

Christian Gisselbrecht • 5 Dec 2014

ASH 2014

B-Cell Lymphoma

At the 2014 American Society of Hematology (ASH) Annual Meeting, Prof Christian Gisselbrecht (St. Louis Hospital, Paris, France) discusses the molecular approach in managing diffuse large B-cell lymphoma (DLBCL). The molecularly defined DLBCL subtypes, germinal centre B-cell-like (GCB)-DLBCL and activated B-cell-like (ABC)-DLBCL, have important clinical implications.